May 16, 2019 (Friday) |
08:30-09:30 |
Registration |
09:30-09:50 |
Welcome Remarks
Dr. Byung-Hoon Lee(President of KSOT, Seoul National University, Korea)
Dr. (TBA) (Director General, National Institute of Food and Drug Safety Evaluation, Korea)
Dr. Chang Woo Song (President of Korea Institute of Toxicology, Korea)
|
09:50-10:30 |
Plenary Lecture 1
Mukunghwa Hall (2F)
Chaired by Dr. Jin-Ho Chung (Seoul National University, Korea)
Understanding Adaptive Response to Electrophilic Stress
Dr. Yoshito Kumagai (University of Tsukuba, President of JSOT, Japan)
|
10:30-10:40 |
Coffee Break |
10:40-12:20 |
Session 1
Mukunghwa Hall (2F)
Redox Biology in Human Diseases
Chaired by Dr. Kyu-Bong Kim (Dankook University, Korea)
|
10:40-11:20 Special Lecture: NRF2-mediated Adaptive Response
in Cancer: the Good, the Bad and the Ugly
Dr. Jingbo Pi (China Medical University, China)
11:20-11:50 Understanding Activation and Signaling Pathway of NADPH Oxidase
in Cell Death, Survival and Proliferation
Dr. Jung-Ae Kim (Yeungnam University, Korea)
11:50-12:20 Protective Role of Sestrin2 as a Link between Oxidative Stress and Inflammation in Liver Diseases
Dr. Sung Hwan Ki (Chosun University, Korea)
|
12:20-14:00 |
Lunch Council Meeting |
14:00-15:40 |
Session 2
Mukunghwa Hall (2F)
Toxicological Research on Oligonucleotide-based Therapeutics (KIT Session)
Chaired by Dr. Tae-Won Kim (Ionis Pharmaceuticals, USA)
|
14:00-14:35 Delivering on The Promise of Oligonucleotide Therapies
Dr. Arthur A. Levin (Avidity Biosciences LLC, USA)
14:35-15:00 Development Path for Tegsedi:
An Antisense Treatment for Hereditary TTR Polyneuropathy
Dr. Scott P. Henry (Ionis Pharmaceuticals, USA)
15:00-15:25 RNAi Therapeutics Development Using Asymmetric siRNAs
Dr. Dong-ki Lee (OliX Pharmaceuticals, Korea)
15:25-15:40 Monkey Toxicity Study for Oligonucleotide-based Therapeutics
Hae Jin Yoon (Korea Institute of Toxicology, Korea)
|
15:40-16:00 |
Coffee Break |
16:00-17:30 |
Session 3
Mukunghwa Hall (2F)
Systems Approach in Toxicology
Chaired by Dr. Jinhee Choi (University of Seoul, Korea)
|
Session 4
Mokryen Hall (1F)
New Platform Models for Toxicity Evaluation
Chaired by Dr. Ki Taek Nam (Yonsei University, Korea)
|
16:00-16:30 Comparison between In-vivo and In-vitro Metabolomics Profiling in Toxicity Study
Dr. Suhkmann Kim (Pusan National University, Korea)
16:30-17:00 Quantitative Toxicoproteomics and Liver Injury Mechanism Dr. Sangkyu Lee (Kyungpook National University, Korea)
17:00-17:30 Gene Expression Profiling in Colorectal Cancer Using Systems Biology Approach
Dr. Jeong-Rae Kim (University of Seoul, Korea)
|
16:00-16:30
Is It Possible to Identify Skin Sensitizers in Bacterial Cultures?
Dr. Tae Cheon Jeong (Yeungnam University, Korea)
16:30-17:00
In Silico Organ-similarity Prediction System for hPSC-derived Human Organoids
Dr. Hyun-Soo Cho (Korea Research Institute of Bioscience and Biotechnology, Korea)
17:00-17:30
For Further Accurate Toxicity Evaluation: Applications of Human Induced Pluripotent Stem Cells
Dr. Dong-Hun Woo (NEXEL Co., Ltd., Korea)
|
17:30-17:40 |
Closing Remarks |
17:40 |
Reception |